News
By Amina Niasse NEW YORK (Reuters) -UnitedHealth Group investors, stunned by missteps at the once predictable healthcare ...
UnitedHealth Group will stop compensative brokers and sales agents who sell new Medicare Part D prescription drug plans.
Ken Cohen, a physician and Optum’s executive director of translational research, said Thursday at a conference organized by ...
UnitedHealth's challenges are manageable, leadership changes boost confidence, and long-term growth shows promise with 15% ...
An analyst reluctantly downgraded UnitedHealth’s stock, as the price plunge and a suspended full-year outlook was just too ...
UnitedHealth has faced several headwinds in the recent past, ranging from a cyberattack, which had greater than initially ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback